CombiMatrix's Q2 Revenues Rise 51 Percent; Names New CEO | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today reported a 51 percent increase in its second-quarter 2010 revenues while naming a new CEO.

The Irvine, Calif.-based firm, which is near completion of its restructuring, brought in total revenues of $916,000 for the three-month period ended June 30, compared to $606,000 for the second quarter of 2009. Of that total, $796,000 came from services and $120,000 from products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.